Adiponectin improves coronary no-reflow injury by protecting the endothelium in rats with type 2 diabetes mellitus

Bioscience Reports

Volumn 37, Issue 4, 2017, Pages

  Han, Xue ^a   Wu, Ye ^a   Liu, Xin ^a   Ma, Lu ^b   Lv, Tingting ^a   Sun, Qi ^a   Xu, Wenli ^a   Zhang, Suli ^a   Wang, Ke ^a   Wang, Wen ^a   Ma, Xinliang ^a,c   Liu, Huirong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; ICAM1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE EXACERBATION; HEART FUNCTION; HEART PROTECTION; HYPOADIPONECTINEMIA; MALE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NO REFLOW PHENOMENON; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; RAT; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADIPONECTIN; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; INTERCELLULAR ADHESION MOLECULE-1; MALE; NO-REFLOW PHENOMENON; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 85029595656     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20170282     Document Type: Article

References (34)

1. Keeley, E.C., Boura, J.A. and Grines, C.l. (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: aquantitative review of 23 randomised trials. Lancet 361, 13–20
2. Rezkalla, S.H. and Kloner, R.A. (2008) Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter. Cardiovasc. Interv. 72, 950–957
3. Niccoli, G., Burzotta, F., Galiuto, L. and Crea, F. (2009) Myocardial No-Reflow in Humans. J. Am. Coll. Cardiol. 54, 281–292
4. Chan, W., Stub, D., Clark, D.J., Ajani, A.E., Andrianopoulos, N., Brennan, A.L. et al. (2012) Usefulness of Transient and Persistent No Reflow to Predict Adverse Clinical Outcomes Following PercutaneousCoronary Intervention. Am. J. Cardiol. 109, 478–485
5. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E. et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930–1935
6. Pischon, T., Girman, C.J., Hotamisligil, G.S., Rifai, N., Hu, F.B. and Rimm, E.B. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291, 1730–1737
7. Shibata, R., Sato, K., Pimentel, D.R., Takemura, Y., Kihara, S., Ohashi, K. et al. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11, 1096–1103
8. Liu, H.R., Zhao, R.R., Jiao, X.Y., Wang, Y.Y. and Fu, M. (2002) Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta(1)-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J. Am. Coll. Cardiol. 39, 1866–1873
9. Hale, S.L., Dae, M.W. and Kloner, R.A. (2003) Hypothermia during reperfusion limits ‘no-reflow’ injury in a rabbit model of acute myocardial infarction. Cardiovasc. Res. 59, 715–722
10. Krueger, M.A., Huke, S.S. and Glenny, R.W. (2013) Visualizing regional myocardial blood flow in the mouse. Circ. Res. 112, e88–e97
11. Hamdy, N.M., Suwailem, S.M. and El-Mesallamy, H.O. (2009) Influence of vitamin E supplementation on endothelial complications in type 2 diabetes mellitus patients who underwent coronary artery bypass graft. J. Diabetes Complications 23, 167–173
12. Halter, J.B., Musi, N., McFarland Horne, F., Crandall, J.P., Goldberg, A., Harkless, L. et al. (2014) Diabetes and cardiovascular disease in older adults: current status and future directions. Diabetes 63, 2578–2589
13. Ankush, Dias A, Gomes, E. and Dessai, A. (2016) Complications in Advanced Diabetics in a Tertiary Care Centre: A Retrospective Registry-Based Study. J. Clin. Diagn. Res. 10, OC15–OC19
14. Laughlin, M.H., Newcomer, S.C. and Bender, S.B. (2008) Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype. J. Appl. Physiol. 104, 588–600
15. Cade, WT. (2008) Diabetes-relatedmicrovascular andmacrovascular diseases in the physical therapy setting. Phys. Ther. 88, 322–335
16. Addabbo, F., Montagnani, M. and Goligorsky, M.S. (2009) Mitochondria and reactive oxygen species. Hypertension 53, 885–892
17. Hirose, A., Tanikawa, T., Mori, H., Okada, Y. and Tanaka, Y. (2010) Advanced glycation endproducts increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS Lett. 584, 61–66
18. Li, S., Shin, H.J., Ding, E.L. and van Dam, R.M. (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302, 179e88
19. Niccoli, G., Lanza, G.A., Shaw, S., Romagnoli, E., Gioia, D., Burzotta, F. et al. (2006) Endothelin-1 and acutemyocardial infarction: a no-reflow mediator after successful percutaneousmyocardial revascularization. Eur. Heart. J. 27, 1793–1798
20. Galiuto, L., DeMaria, A.N., del Balzo, U., May-Newman, K., Flaim, S.F., Wolf, P.L. et al. (2000) Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography. Circulation 102, 3111–3116
21. Osborn, L., Hession, C. and Tizard, R. (1989) Direct expression clorning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds lymphoeytes. Cell 59, 1203–1211
22. Paine, R. and Ward, P.A. (1999) Cell adhesion molecule and pulmonary fibrosis. Am. J. Med. 107, 268–279
23. Vykoukal, D. and Mark, G. (2011) Davies.vascular biology of metabolic syndrome. J. Vasc. Surg. 54, 819–831
24. Li, Y. (2015) Correlation analysis of levels of adiponectin and matrix metalloproteinase-9 with stability of coronary heart disease. Technol. Health. Care 23, S95–S98
25. Tao, L., Gao, E., Jiao, X., Yuan, Y., Li, S., Christopher, T.A. et al. (2007) Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative Stress. Circulation 115, 1408–1416
26. Pilz, S., Maerz, W., Weihrauch, G., Sargsyan, K., Almer, G., Nauck, M. et al. (2006) Adiponectin serum concentrations in men with coronary artery disease; the LUdwigshafen Risk and Cardiovascular Health(LURIC) study. Clin. Chim. Acta. 364, 251–258
27. Kusmic, C., L’abbate, A., Sambuceti, G., Drummond, G., Barsanti, C., Matteucci, M. et al. (2010) Improved Myocardial Perfusion in Chronic Diabetic Mice by the Up-Regulation of pLKB1 and AMPK Signaling. J. Cell. Biochem. 109, 1033–1044
28. Zhao, L., Chai, W., Fu, Z., Dong, Z., Aylor, K.W., Barrett, E.J. et al. (2013) Globular Adiponectin Enhances Muscle Insulin Action via Microvascular Recruitment and Increased Insulin Delivery. Circ. Res. 112, 1263–1271
29. Alvarez, G., Visitación Bartolomé, M., Miana, M., Jurado-López, R., Martín, R., Zuluaga, P. et al. (2012) The Effects of Adiponectin and Leptin on Human Endothelial Cell Proliferation:A Live-Cell Study. J. Vasc. Res. 49, 111–122
30. Motoshima, H., Wu, X., Mahadev, K. and Goldstein, B.J. (2004) Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem. Biophys. Res. Commun. 315, 264e71
31. Zhi, Z., Pengfei, Z., Xiaoyi, T. and Genshan, M. (2014) Adiponectin ameliorates angiotensin II-induced vascular endothelial damage. Cell Stress Chaperones 19, 705–713
32. Zheng, Q., Yuan, Y., Yi, W., Lau, W.B., Wang, Y., Wang, X. et al. (2011) C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway. Arterioscler. Thromb. Vasc. Biol. 31, 2616–2623
33. Zhang, Y., Wang, X.L., Zhao, J., Wang, Y.J., Lau, W.B., Yuan, Y.X. et al. (2013) Adiponectin inhibits oxidative/nitrative stress during myocardial ischemia and reperfusion via PKA signaling. Am. J. Physiol. Endocrinol. Metab. 305, E1436–E1443
34. Wang, Y., Wang, X., Lau, W.B., Yuan, Y., Booth, D., Li, J.J. et al. (2014) Adiponectin Inhibits Tumor Necrosis Factor-α-Induced Vascular Inflammatory Response via Caveolin-Mediated Ceramidase Recruitment and Activation. Circ. Res. 114, 792–805